Transcatheter closure of fenestrated atrial septal aneurysm in children: Feasibility and long-term results.
atrial septal aneurysm
atrial septal defect
long term
multifenestrated
pediatric
percutaneous
Journal
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
ISSN: 1522-726X
Titre abrégé: Catheter Cardiovasc Interv
Pays: United States
ID NLM: 100884139
Informations de publication
Date de publication:
06 2022
06 2022
Historique:
revised:
17
02
2022
received:
23
07
2021
accepted:
23
03
2022
pubmed:
15
4
2022
medline:
10
6
2022
entrez:
14
4
2022
Statut:
ppublish
Résumé
To date, extensive experience in transcatheter closure of fenestrated atrial septal aneurysm (ASA) in the pediatric population is limited. To report on procedural feasibility, efficacy, and long-term outcome, we enrolled all children submitted to an attempt of transcatheter closure of fenestrated ASA at two, large volume, pediatric cardiology units (Naples and Massa, Italy) between April 2000 to May 2020. This retrospective study included 139 patients (median age 9 years [range 2-18] and weight 36 kg [range 10-102]); 19 (13.7%) children were ≤20 kg (range 10-20) and 14 (10.1%) were ≤5 years old. Single perforation was observed in 28 patients (20.1%), while 111 patients (79.9%) had multifenestrated ASA. The median size of the main defect was 15 mm (range 6-34) and 25 patients (18%) had a defect ≥20 mm. The procedural success rate was 99% (95% confidence interval [CI]: 94.9-99.8) using a single device in 75 (69%), two devices in 31 (28%), and three devices in 3 (3%) cases. Early minor adverse events (AEs) occurred in four patients (2.8%). Late minor AEs were recorded in one patient (0.7%) over a median follow-up of 5 years ([range 0-18 years; total 890.2 person-years, and with 30 patients (22%) followed ≥10 years). Neither mortality nor major AEs were recorded. Freedom from AEs was 99.1% at 10-15 years (95% CI: 93.5-99.8%), without any difference according to atrial septum anatomy or patient age and weight. Transcatheter closure of fenestrated ASA is technically feasible and effective in children with excellent long-term outcomes.
Sections du résumé
BACKGROUND
To date, extensive experience in transcatheter closure of fenestrated atrial septal aneurysm (ASA) in the pediatric population is limited.
METHODS
To report on procedural feasibility, efficacy, and long-term outcome, we enrolled all children submitted to an attempt of transcatheter closure of fenestrated ASA at two, large volume, pediatric cardiology units (Naples and Massa, Italy) between April 2000 to May 2020.
RESULTS
This retrospective study included 139 patients (median age 9 years [range 2-18] and weight 36 kg [range 10-102]); 19 (13.7%) children were ≤20 kg (range 10-20) and 14 (10.1%) were ≤5 years old. Single perforation was observed in 28 patients (20.1%), while 111 patients (79.9%) had multifenestrated ASA. The median size of the main defect was 15 mm (range 6-34) and 25 patients (18%) had a defect ≥20 mm. The procedural success rate was 99% (95% confidence interval [CI]: 94.9-99.8) using a single device in 75 (69%), two devices in 31 (28%), and three devices in 3 (3%) cases. Early minor adverse events (AEs) occurred in four patients (2.8%). Late minor AEs were recorded in one patient (0.7%) over a median follow-up of 5 years ([range 0-18 years; total 890.2 person-years, and with 30 patients (22%) followed ≥10 years). Neither mortality nor major AEs were recorded. Freedom from AEs was 99.1% at 10-15 years (95% CI: 93.5-99.8%), without any difference according to atrial septum anatomy or patient age and weight.
CONCLUSION
Transcatheter closure of fenestrated ASA is technically feasible and effective in children with excellent long-term outcomes.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2043-2053Informations de copyright
© 2022 Wiley Periodicals LLC.
Références
Olivares-Reyes A, Chan S, Lazar EJ, Bandlamudi K, Narla V, Ong K. Atrial septal aneurysm: a new classification in two hundred five adults. J Am Soc Echocardiogr. 1997;10(6):644-656.
Ewert P, Berger F, Vogel M, Dahnert I, Alexi-Meshkishvili V, Lange PE. Morphology of perforated atrial septal aneurysm suitable for closure by transcatheter device placement. Heart. 2000;84(3):327-331.
Jatav RK, Kumbhare MB, Surender T, Rachan C, Krishna T. Atrial septal aneurysm in adult patients: spectrum of clinical, echocardiographic presentation and to propose a new classification on the basis of trans-thoracic-two-dimensional echocardiography. Int J Res Med Sci. 2014;2(2):708.
Baysal K, Belet N, Kolbakir F, Yalin T. Atrial septal aneurysm in children. Turk J Pediatr. 2001;43(4):293-297.
Santoro G, Bigazzi MC, Lacono C, et al. Transcatheter closure of complex atrial septal defects: feasibility and mid-term results. J Cardiovasc Med. 2006;7(3):176-181.
Krumsdorf U, Keppeler P, Horvath K, Zadan E, Schrader R, Sievert H. Catheter closure of atrial septal defects and patent foramen ovale in patients with an atrial septal aneurysm using different devices. J Interv Cardiol. 2001;14(1):49-55.
Numan MT, El-Said H, Dilawar M, El, Sisi A. The challenge of fenestrated atrial septal defects closure; which device to choose? Cardiovasc Disord Med. 2018;3(5):1-4.
Ali SH, El Sisi A, Raafat DM, Amry SE, Mahamoud SED. Short-term outcomes of transcatheter closure of secundum atrial septal defect in children and adolescents: an experience of two centers in Upper Egypt. J Saudi Heart Assoc. 2018;30(1):14-20.
Grohmann J, Wildberg C, Zartner P, et al. Multicenter midterm follow-up results using the gore septal occluder for atrial septal defect closure in pediatric patients. Catheter Cardiovasc Interv. 2017;89(7):E226-E232.
Knop MT, Bialkowski J, Szkutnik M, et al. Transcatheter closure of atrial septal defects type 2 in children under three years of age. Kardiol Pol. 2018;76(8):1257-1262.
Bramlet MT, Hoyer MH. Single pediatric center experience with multiple device implantation for complex secundum atrial septal defects. Catheter Cardiovasc Interv. 2008;72(4):531-537.
Hanley PC, Tajik AJ, Hynes JK, et al. Diagnosis and classification of atrial septal aneurysm by two-dimensional echocardiography: report of 80 consecutive cases. J Am Coll Cardiol. 1985;6(6):1370-1382.
Mahmoud HT, Gaio G, Giordano M, et al. Transcatheter closure of fenestrated atrial septal aneurysm: feasibility and long-term results. J Cardiovasc Med (Hagerstown). 2022;23(1):49-59. https://doi.org/10.2459/JCM.0000000000001239
Giordano M, Gaio G, Santoro G, et al. Patent foramen ovale with complex anatomy: comparison of two different devices (Amplatzer Septal Occluder device and Amplatzer PFO Occluder device 30/35). Int J Cardiol. 2019;279:47-50.
Fischer G, Stieh J, Uebing A, Hoffmann U, Morf G, Kramer HH. Experience with transcatheter closure of secundum atrial septal defects using the Amplatzer septal occluder: a single centre study in 236 consecutive patients. Heart. 2003;89(2):199-204.
Kaulitz R, Peuster M, Jux C, Paul T, Hausdorf G. Transcatheter closure of various types of defects within the oval fossa using the double umbrella device (CardioSEAL)-feasibility and echocardiographic follow-up. Cardiol Young. 2001;11(2):214-222.
Dobrolet NC, Iskowitz S, Lopez L, Whalen R, Zahn EM. Sequential implantation of two Helex septal occluder devices in a patient with complex atrial septal anatomy. Catheter Cardiovasc Interv. 2001;54(2):242-246.
Peruga J, Krecki R, Chrzanowski L, Krzeminska-Pakula M, Kasprzak JD. Implantation of the Figulla Occlutech device in a patient with an ostium secundum atrial septal defect. Kardiol Pol. 2008;66(6):658-660.
Mahmoud HT, Santoro G, Capogrosso C, Russo MG. Off-label use of Amplatzer Duct Occluder II additional sizes. J Cardiovasc Med. 2017;18(6):436-442.
Boutin C, Musewe NN, Smallhorn JF, Dyck JD, Kobayashi T, Benson LN. Echocardiographic follow-up of atrial septal defect after catheter closure by double-umbrella device. Circulation. 1993;88(2):621-627.
Chessa M, Carminati M, Butera G, et al. Early and late complications associated with transcatheter occlusion of secundum atrial septal defect. J Am Coll Cardiol. 2002;39(6):1061-1065.
Jalal Z, Hascoët S, Gronier C, et al. Long-term outcomes after percutaneous closure of ostium secundum atrial septal defect in the young: a nationwide cohort study. JACC Cardiovasc Interv. 2018;11(8):795-804.
Haas NA, Happel CM, Soetemann DB, et al. Optimal septum alignment of the Figulla Flex occluder to the atrial septum in patients with secundum atrial septal defects. EuroIntervention. 2016;11(10):1153-1160.
Numan M, El Sisi A, Tofeig M, Gendi S, Tohami T, El-Said HG. Cribriform amplatzer device closure of fenestrated atrial septal defects: feasibility and technical aspects. Pediatr Cardiol. 2008;29(3):530-535.
Masseli J, Bertog S, Stanczak L, et al. Transcatheter closure of multiple interatrial communications. Catheter Cardiovasc Interv. 2013;81(5):825-836.
Haas NA, Soetemann DB, Ates I, et al. Closure of secundum atrial septal defects by using the occlutech occluder devices in more than 1300 patients: the IRFACODE Project: a retrospective case series. Catheter Cardiovasc Interv. 2016;88(4):571-581.
Hornung M, Bertog SC, Franke J, et al. Long-term results of a randomized trial comparing three different devices for percutaneous closure of a patent foramen ovale. Eur Heart J. 2013;34(43):3362-3369.
Wahl A, Krumsdorf U, Meier B, et al. Transcatheter treatment of atrial septal aneurysm associated with patent foramen ovale for prevention of recurrent paradoxical embolism in high-risk patients. J Am Coll Cardiol. 2005;45(3):377-380.
Harper RW, Mottram PM, McGaw DJ. Closure of secundum atrial septal defects with the Amplatzer septal occluder device: techniques and problems. Catheter Cardiovasc Interv. 2002;57(4):508-524.
Price MJ. Transcatheter closure of patent foramen ovale devices and technique. Interv Cardiol Clin. 2017;6(4):555-567.
Chan KC, Godman MJ, Walsh K, Wilson N, Redington A, Gibbs JL. Transcatheter closure of atrial septal defect and interatrial communications with a new self expanding nitinol double disc device (Amplatzer septal occluder): multicentre UK experience. Heart. 1999;82(3):300-306.
Kokkinidis DG, Rios SA, Avendano R, Zaidi A, Faillace RT. Embryology, Anatomy, and Physiology: Anatomical Variations, Lipomatous Hypertrophy, Atrial Septal Aneurysm, Eustachian Valve, Chiari Network, Combination With Other Atrial Septal Defects. Patent Foramen Ovale Closure for Stroke, Myocardial Infarction, Peripheral Embolism, Migraine, and Hypoxemia. Elsevier; 2020:3-12.
Szkutnik M, Masura J, Bialkowski J, et al. Transcatheter closure of double atrial septal defects with a single Amplatzer device. Catheter Cardiovasc Interv. 2004;61(2):237-241.
Ewert P, Berger F, Kretschmar O, Abdul-Khaliq H, Stiller B, Lange PE. Feasibility of transcatheter closure of multiple defects within the oval fossa. Cardiol Young. 2001;11(3):314-319.
Podnar T, Martanovic P, Gavora P, Masura J. Morphological variations of secundum-type atrial septal defects: feasibility for percutaneous closure using Amplatzer septal occluders. Catheter Cardiovasc Interv. 2001;53(3):386-391.
Awad SM, Garay FF, Cao QL, Hijazi ZM. Multiple Amplatzer septal occluder devices for multiple atrial communications: immediate and long-term follow-up results. Catheter Cardiovasc Interv. 2007;70(2):265-273.
Cao Q, Radtke W, Berger F, Zhu W, Hijazi ZM. Transcatheter closure of multiple atrial septal defects. Initial results and value of two- and three-dimensional transoesophageal echocardiography. Eur Heart J. 2000;21(11):941-947.
Butera G, Romagnoli E, Saliba Z, et al. Percutaneous closure of multiple defects of the atrial septum: procedural results and long-term follow-up. Catheter Cardiovasc Interv. 2010;76(1):121-128.
Akula VS, Durgaprasad R, Velam V, Kasala L, Rodda M, Erathi HV. Right ventricle before and after atrial septal defect device closure. Echocardiography. 2016;33(9):1381-1388.
Mainzer G, Braver Y, Khoury A, et al. Morphologic, mechanical, conductive, and hemodynamic changes following transcatheter closure of atrial septal defect. Congenit Heart Dis. 2010;5(1):25-31.
Kaya MG, Baykan A, Dogan A, et al. Intermediate-term effects of transcatheter secundum atrial septal defect closure on cardiac remodeling in children and adults. Pediatr Cardiol. 2010;31(4):474-482.